Galera Therapeutics, Inc. GRTX
17.15 USD 0.00 (+0.00%)
Aug 3, 2026, 2:11 PM EDT
16.00 Day range 17.15
0.01 52-week range 16.70
- YTD
- +77,854.55%
- 1 year
- +59,037.93%
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 29, 2023 | Citigroup | Maintained | Neutral | Neutral |
| Aug 16, 2023 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Aug 10, 2023 | Piper Sandler | Downgrade | Overweight | Neutral |
| Jul 17, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 22, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Feb 21, 2023 | Piper Sandler | Initiated | — | Overweight |
| Feb 16, 2023 | B of A Securities | Upgrade | Underperform | Buy |
| Feb 16, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| May 27, 2022 | B of A Securities | Downgrade | Neutral | Underperform |
| Dec 20, 2021 | Citigroup | Maintained | — | Buy |
| Dec 15, 2021 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
| Dec 15, 2021 | BTIG | Upgrade | Neutral | Buy |
| Oct 20, 2021 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Oct 19, 2021 | BTIG | Downgrade | Buy | Neutral |
| Dec 16, 2020 | Credit Suisse | Upgrade | Neutral | Outperform |
| Dec 7, 2020 | HC Wainwright & Co. | Initiated | — | Buy |
| Nov 11, 2020 | Credit Suisse | Maintained | — | Neutral |
| Jul 29, 2020 | Credit Suisse | Maintained | — | Neutral |
| Dec 2, 2019 | BTIG | Initiated | — | Buy |
| Dec 2, 2019 | B of A Securities | Initiated | — | Buy |
| Dec 2, 2019 | Citigroup | Initiated | — | Buy |
| Dec 2, 2019 | Credit Suisse | Initiated | — | Neutral |